A study to compare the elimination of gadolinium-based contrast agents gadobutrol using sustained low efficiency daily dialysis (SLEED) with intermittent hemodialysis (iHD) in ICU patients and normal ward inpatients
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Gadobutrol (Primary)
- Indications Atrial fibrillation; Hepatorenal syndrome; Hypertension; Kidney disorders; Renal failure; Systemic lupus erythematosus
- Focus Pharmacokinetics
Most Recent Events
- 18 Jun 2020 New trial record